The PCPT trial

The PCPT trial

Показать другие версии (2)

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

Полное описание

Библиографические подробности
Главные авторы:	Hamdy, F, Rouprêt, M
Формат:	Journal article
Язык:	French
Опубликовано:	2008

Схожие документы

[The PCPT trial].
по: Hamdy, F, и др.
Опубликовано: (2008)

The PCPT trial
по: Hamdy, F, и др.
Опубликовано: (2008)

Estimating Hydraulic Conductivity of Overconsolidated Soils Based on Piezocone Penetration Test (PCPT)
по: Binyam M. Bekele, и др.
Опубликовано: (2021-02-01)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT)/
по: 207490 Ismail Bakar, и др.
Опубликовано: (1981)

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
по: Ankerst, D, и др.
Опубликовано: (2012)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT) / [mikrofilem]
по: 207490 Ismail Bakar

A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
по: Samuel Carbunaru, и др.
Опубликовано: (2019-11-01)

Time-dependent behavior of full-scale precast post-tensioned (PCPT) girders: Experimental and finite element analysis
по: Panuwat Joyklad, и др.
Опубликовано: (2022-12-01)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
по: Enrique Gomez Gomez, и др.
Опубликовано: (2019-11-01)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
Опубликовано: (2020-02-01)

Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
по: A.B. Silva, и др.
Опубликовано: (2020-11-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
по: Christiano Tansol, и др.
Опубликовано: (2017-07-01)

Becoming editor-in-chief of European Urology Oncology: The 4 pillars of the development strategy
по: M. Rouprêt
Опубликовано: (2023-11-01)

Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
по: Yates, DR, и др.
Опубликовано: (2013)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
по: Rouprêt, M, и др.
Опубликовано: (2005)

The prostate cancer prevention trial and its messages.
по: Hamdy, F
Опубликовано: (2007)

Clinically localised prostate cancer is microsatellite stable.
по: Azzouzi, A, и др.
Опубликовано: (2007)

Word of wisdom. Re: mortality results from the Goteborg randomised population-based prostate-cancer screening trial.
по: Hamdy, F
Опубликовано: (2010)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
по: Rouprêt, M, и др.
Опубликовано: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
по: Roupret, M, и др.
Опубликовано: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
по: Roupret, M, и др.
Опубликовано: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
по: Hamdy, F, и др.
Опубликовано: (2003)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
по: Elisabeth Grobet-Jeandin, и др.
Опубликовано: (2021-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
по: Roupret, M, и др.
Опубликовано: (2004)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
по: Rouprêt, M, и др.
Опубликовано: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
по: Roupret, M, и др.
Опубликовано: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
по: Elliott, D, и др.
Опубликовано: (2017)

Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: A pilot single-center study
по: E. Chartier-Kastler, и др.
Опубликовано: (2020-07-01)

Addressing patient treatment preferences at trial recruitment.
по: Mills, N, и др.
Опубликовано: (2011)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
по: Lane, J, и др.
Опубликовано: (2009)

[Early diagnosis and surgical management of prostate cancer]
по: Linton, D, и др.
Опубликовано: (2004)

Early diagnosis and surgical management of prostate cancer
по: Linton, D, и др.
Опубликовано: (2004)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
по: Donovan, J, и др.
Опубликовано: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
по: Lane, J, и др.
Опубликовано: (2007)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
по: Mills, N, и др.
Опубликовано: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
по: Mills, N, и др.
Опубликовано: (2011)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
по: Mills, N, и др.
Опубликовано: (2003)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
по: Alae Touzani, и др.
Опубликовано: (2022-11-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
по: Lane, J, и др.
Опубликовано: (2004)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
по: Catto, J, и др.
Опубликовано: (2017)